NHMRC Call for Applications: MRFF – 2022 Assessment of High-Cost Gene Treatments and Digital Health Interventions Grant
The Australian National Health and Medicine Research Council (NHMRC) is calling for applications to the Medical Research Future Fund (MRFF) – 2022 Assessment of High-Cost Gene Treatments and Digital Health Interventions Grant.
Objective:
To provide grants of financial assistance to support medical research and medical innovation projects that:
- Stream 1 (Targeted Call for Research (TCR): develop a generalisable model to support assessment and validation of the clinical effectiveness and cost-effectiveness of new and emerging high upfront-cost therapeutics which includes consideration of ethical, legal, social and cultural aspects.
- Stream 2 (TCR): conduct an implementation trial in both rural/remote and major city settings utilising the continuous remote monitoring capabilities of pacemakers and implantable cardioverter defibrillators to assess their health and non-health outcomes such as patient preferences, usability and cost effectiveness and appropriateness.
- Stream 3 (TCR): undertake a retrospective or prospective evaluation of an implementation of a digital health intervention in order to assess the relative impact of augmenting face-to-face care with data from digital tools that advances assessment methods for digital innovations.
Eligibility:
- Applications will only be accepted from approved MRFF Eligible Organisations.
- Applications must satisfy all the requirements set out in the MRFF – Preventive and Public Health Research Initiative – 2022 Assessment of High-Cost Gene Treatments and Digital Health Interventions Grant Opportunity Guidelines.
Funding details:
- From $0.00 to $1,500,000.00 for a maximum duration of 4 years.
Read more here.
Important dates
- Minimum data due January 31, 2023.
- Applications deadline March 1, 2023.
